However, in RB-treated glioma cells, we found that Ca2+ was significantly elevated after activation of Na+-K+-ATPase by RB, which inhibited the Src/FAK/Paxillin focal adhesion pathway. The gene discussed is SRC; the disease is central nervous system cancer.